Symposium Program
| 10:00am | Registration & Coffee |
Chair: Andrew Biankin and Anthony Gill
| 10:30am |
Welcome by Andrew Biankin |
| 10:45am |
Welcome & Introduction by Warwick Anderson |
| 10:55am |
APGI Sequencing Update by Sean Grimmond |
| 11:15am |
New Sequencing Developments by Richard Gibbs |
| APGI Member Activities: | |
| 11:45am | The Queensland Pancreatic Cancer Study by Rachel Neale |
| 12:00pm | Adjuvant Radiation Treatment in Pancreatic Cancer: A National Overview by Chelsie O'Connor |
| 12:15pm | 'Outliers' in Pancreatic Cancer by Lorraine Chantrill |
| 12:30pm | Circulating DNA as a personalised biomarker in Pancreatic Cancer by Venessa Chin |
| 12:45pm | Questions and Discussion |
| 12:55pm | Light Lunch and Discussion |
Chair: Sean Grimmond
| 2:00pm |
Clinical Applications of Next Generation Sequencing by John McPherson |
|---|---|
| 2:30pm |
A Step forward for Endoscopic Ultrasound (EUS) Guided Biopsy in the Era of Biomarkers by Nam Nguyen |
| 2:45pm |
Clinical Implementation: Treatment and Screening by Andrew Biankin |
| 3:05pm | Coffee |
Chair: Amber Johns
| 3:35pm |
Return of Results: A Policy and Ethical Overview by Nik Zeps Research Manager at St John of God Pathology in Perth WA, and Member of the Australian Health Ethics Committee (AHEC) of NHMRC |
| 3:50pm | Return of Results: Ethical Implications by Jack Goldblatt Director of Genetic Services & Familial Cancer Program of Western Australia. |
| 4:15pm | Discussion lead by Jack Goldblatt
|
| 4:35pm | Closing remarks by Andrew Biankin |
| 5:00pm |
Close of Meeting Drinks in the Garvan Galleria |
